Literature DB >> 30594429

Systematic Review of Endovascular, Surgical, and Conservative Options for Infectious Intracranial Aneurysms and Cardiac Considerations.

Ranjan Ragulojan1, Stephen Grupke2, Justin F Fraser3.   

Abstract

INTRODUCTION: With rising rates of intravenous drug use, Infectious Intracranial aneurysms (IIAs) are a relevant topic for investigation. We performed a systematic review to better understand current practice patterns and limits of current published literature.
METHOD: 131 publications with a total of 499 patients (665 aneurysms) were included. Of the 499 patients, 83 were single case reports, and 20.5% of the total had multiple aneurysms. 35.8% of all aneurysms were ruptured. Of those reporting treatment, options included conservative antibiotic therapy (30.0%), open surgical intervention (31.1%), and endovascular occlusion (31.8%). Chronologically, publication of IIAs has increased. Usage of endovascular therapies has grown, while conservative and surgical management have declined in the literature. Overall, 56.2% of aneurysms for which conservative therapy was initiated eventually either underwent intervention or death of patient occurred.
RESULTS: The issue of cardiac valve surgery in relationship to aneurysm therapy was discussed in 20.8% (80 patients) of all 384 infectious endocarditis patients; of which 15.0% (12) underwent valve surgery before aneurysm treatment and 85.0 patients (68)% underwent valve surgery after aneurysm treatment. For 51 of the patients where valve surgery followed aneurysm management, the corresponding aneurysm treatment modality could be determined; 58.8% (30) of whom were managed endovascularly. 32.7% (26) of all cases reporting cardiac surgery details underwent cardiac surgery during their admission with the IIA.
CONCLUSIONS: Overall, increasing trend of endovascular management of IIAs is evident, and a strong temporal preference exhibited by providers to perform cardiac surgery subsequently to IIA management.
Copyright © 2018 National Stroke Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Infectious intracranial aneurysms—mycotic aneurysms—systematic review—management—endovascular—surgical

Mesh:

Substances:

Year:  2018        PMID: 30594429     DOI: 10.1016/j.jstrokecerebrovasdis.2018.11.035

Source DB:  PubMed          Journal:  J Stroke Cerebrovasc Dis        ISSN: 1052-3057            Impact factor:   2.136


  5 in total

1.  Endovascular treatment of infectious intracranial aneurysms complicating infective endocarditis: a series of 31 patients with 55 aneurysms.

Authors:  Fabiola Serrano; Alexis Guédon; Jean-Pierre Saint-Maurice; Marc-Antoine Labeyrie; Vittorio Civelli; Michael Eliezer; Emmanuel Houdart
Journal:  Neuroradiology       Date:  2021-08-30       Impact factor: 2.804

2.  Neurological Outcomes of Patients With Mycotic Aneurysms in Infective Endocarditis.

Authors:  Hang Shi; Neal S Parikh; Charles Esenwa; Richard Zampolin; Harsh Shah; Farid Khasiyev; Ives Valenzuela; Sean Lavine; Jose Gutierrez; Joshua Willey
Journal:  Neurohospitalist       Date:  2020-06-15

Review 3.  Treatment Strategies for Infectious Intracranial Aneurysms: Report of Three Cases and Review of the Literature.

Authors:  Kazuhiro Ando; Hitoshi Hasegawa; Bumpei Kikuchi; Shoji Saito; Jotaro On; Kohei Shibuya; Yukihiko Fujii
Journal:  Neurol Med Chir (Tokyo)       Date:  2019-07-04       Impact factor: 1.742

4.  Simultaneous intracerebral and subarachnoid hemorrhages caused by multiple infectious intracranial aneurysms treated endovascularly and by microsurgical clipping: illustrative case.

Authors:  Ken Akimoto; Kiyoyuki Yanaka; Kazuhiro Nakamura; Hayato Takeda; Minami Saura; Maya Takada; Hisayuki Hosoo; Yuji Matsumaru; Eiichi Ishikawa
Journal:  J Neurosurg Case Lessons       Date:  2022-02-14

5.  Characteristics and Outcomes of Left Ventricular-Assist Device-Associated Cerebrovascular Events in Setting of Infectious Intracranial Aneurysms.

Authors:  Tanu Garg; Shyam Panchal; Tariq Nisar; David McCane; Jason Lee; Ken Chyuan Ling; Barry Trachtenberg; Arvind Bhimaraj; David Chiu; Rajan Gadhia
Journal:  Cureus       Date:  2021-05-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.